News
FDA Suspends U.S. License of Chikungunya Vaccine
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq, in the United States. The move comes after reports of serious side effects in older adults similar to the symptoms of chikungunya virus.
Shares of French drugmaker Valneva slumped more than 20% on Monday after the U.S. Food and Drug Administration suspended the ...
Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...
Panel members have been given a broad mandate, despite pleas from C.D.C. employees asking Robert F. Kennedy Jr. to stop ...
The U.S. Centers for Disease Control and Prevention has chosen Retsef Levi, a member of its key vaccine panel, to lead its ...
An influential vaccine panel’s task force will be led by a member who has previously expressed distrust in the Covid vaccine, ...
As nonmedical exemptions rise across the country, vaccine rates among kindergarteners are steadily decreasing.
The U.S. Centers for Disease Control and Prevention has chosen Retsef Levi, a member of its key vaccine panel, to lead its ...
Fox News senior medical analyst Dr. Marc Siegel weighs in on Health and Human Services Secretary Robert F. Kennedy Jr. criticizing the American Academy of Pediatrics’ COVID vaccine guidance for kids ...
The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...
An international team of scientists has found that a promising African swine fever (ASF) vaccine can protect pigs against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback